Use of biologics in the treatment of hidradenitis suppurativa: a review of the Henry Ford Hospital experience

Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review

(2012) J.L. Blok et al.   BRITISH JOURNAL OF DERMATOLOGY

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study

(2011) H.H. van der Zee et al.   BRITISH JOURNAL OF DERMATOLOGY

Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa

(2011) Dominique C. van Rappard et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial

(2010) Annika Grant et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors

(2009) P Haslund et al.   ACTA DERMATO-VENEREOLOGICA